Maravai Q4 revenue $204.7M, adj EPS $0.35; 2023 guidance $420-460M; acquires Alphazyme

MARAVAI LIFESCIENCES HOLDINGS, INC.

2022-FY EPS reported $1.67 revenue$883,001,000

Q4 revenue $204.7M (-10% YoY); net income $87.4M; adjusted diluted EPS $0.35.
Full year 2022 revenue $883.0M (+10% YoY); net income $490.7M; adjusted EPS $1.80.
Base business revenue (ex-COVID CleanCap) up 67% in Q4 and 17% full year.
2023 revenue guidance $420M-$460M; base business growth expected >20%.
Acquired Alphazyme, LLC (private enzyme manufacturer); announced CEO succession plan.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

MARAVAI LIFESCIENCES HOLDINGS, INC. reported fourth quarter ended December 31, 2022 results: revenue $204.7 million, net income $87.4 million, EPS $0.35.

Period: fourth quarter ended December 31, 2022
Revenue: $204.7 million
Net income: $87.4 million
EPS: $0.35
Result: reported results

Exact text from the filing

Quarterly revenue of $204.7 million, Net income of $87.4 million, and Adjusted fully diluted earnings per share (EPS) of $0.35

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

MARAVAI LIFESCIENCES HOLDINGS, INC. reported full year ended December 31, 2022 results: revenue $883.0 million, net income $490.7 million, EPS $1.80.

Period: full year ended December 31, 2022
Revenue: $883.0 million
Net income: $490.7 million
EPS: $1.80
Result: reported results

Exact text from the filing

Annual revenue of $883.0 million, Net income of $490.7 million and Adjusted fully diluted EPS of $1.80

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

MARAVAI LIFESCIENCES HOLDINGS, INC. reported full year 2023 results: revenue $420.0 million to $460.0 million. Guidance initiated.

Period: full year 2023
Revenue: $420.0 million to $460.0 million
Guidance: initiated
Result: guidance update

Exact text from the filing

Introduced 2023 revenue guidance range of $420.0 million to $460.0 million

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

MARAVAI LIFESCIENCES HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001823239-23-000012

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.